Cite

HARVARD Citation

    Kataoka, H. et al. (2021). Anti-programmed cell death-1 (PD-1) monoclonal antibodies involve reversible cranial dura matter. Oxford medical case reports. 2021 (9), p. . [Online]. 
  
Back to record